NGF and glaucoma: Additionally, a phase II, randomized, double-blind, placebo-controlled trial (NCT02585540) is investigating the potential benefits of recombinant human nerve growth factor (rhNGF) in glaucoma patients, focusing on neuroprotective effects and visual field progression [21,157].